Tag: CRC

Racial differences in colorectal cancer survival linked to health at initial diagnosis

Nivolumab plus Ipilimumab in MSI-High Metastatic Colorectal Cancer

byDaniel Goldshteinand1 others

December 2, 2024

1. Progression-free survival at 12 months was 79% with nivolumab/ipilimumab vs 21% with chemotherapy, and 24-month PFS was 72% and ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Glucagon-like peptide-1 receptor agonists and co-agonists safe and effective for weight loss
Sarcopenia may be associated with an increased risk of cardiovascular disease
Gabapentin may be associated with improved fall-related outcomes in older adults being treated for neuropathic pain

No Result

View All Result